Trials / Completed
CompletedNCT00995423
Comparison of Paclitaxel-Eluting Coroflex Please Stent Versus Paclitaxel-Eluting Stent
Comparison of the Efficacy and Safety of Paclitaxel-Eluting CoroflexTM Please Stent Versus Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- CardioVascular Research Foundation, Korea · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether the outcome of treatment with CoroflexTM Please stent is not inferior to the outcome of treatment with TAXUS stent.
Detailed description
To establish the effectiveness and the safety of coronary stenting with the newly developed paclitaxel-eluting balloon expandable stent (CoroflexTM Please stent, B. Bran, Melsungen, Germany), compared to the conventional paclitaxel-eluting balloon expandable stent (TAXUS stent, Boston scientific) in the treatment of coronary stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CoroflexTM Please | highly flexible CoroflexTM Please-Stent |
| DEVICE | Paclitaxel-eluting stent | Paclitaxel-eluting stent |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-10-15
- Last updated
- 2010-08-18
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00995423. Inclusion in this directory is not an endorsement.